blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2019686

EP2019686 - COMBINED MUCOSAL AND PARENTERAL IMMUNIZATION AGAINST HIV [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.05.2013
Database last updated on 03.10.2024
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): HU, LU		published on 19.08.2015  [2015/34]
Applicant(s)For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
[2012/28]
Former [2009/06]For all designated states
NOVARTIS AG
Lichtstrasse 35
4056 Basel / CH
Inventor(s)01 / RAPPUOLI, Rino
Novartis Vaccines And Diagnostics Inc
P.O. Box 8097
Emeryville, CA 94662-8097 / US
02 / LEWIS, David, J.M.
Novartis Vaccines And Diagnostics Inc.
P.O. Box 8097
Emeryville, CA 94662-8097 / US
03 / BARNETT, Susan, W.
Novartis Vaccines And Diagnostics Inc.
P.O. Box 8097
Emeryville, CA 94662-8097 / US
 [2012/28]
Former [2009/06]01 / RAPPUOLI, Rino
Novartis Vaccines And Diagnostics Inc P.O. Box 8097
Emeryville, CA 94662-8097 / US
02 / LEWIS, David, J.M.
Novartis Vaccines And Diagnostics Inc. P.O. Box 8097
Emeryville, CA 94662-8097 / US
03 / BARNETT, Susan, W.
Novartis Vaccines And Diagnostics Inc. P.O. Box 8097
Emeryville, CA 94662-8097 / US
Representative(s)Marshall, Cameron John, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2012/28]Marshall, Cameron John, et al
Carpmaels & Ransford One Southampton Row London
WC1B 5HA / GB
Former [2009/51]Marshall, Cameron John, et al
Carpmaels & Ransford 43-45 Bloomsbury Square
London WC1A 2RA / GB
Former [2009/06]Marshall, Cameron John, et al
Carpmaels & Ransford 43-45 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date07773929.029.03.2007
[2009/06]
WO2007US07583
Priority number, dateUS20060788563P31.03.2006         Original published format: US 788563 P
US20060840178P26.08.2006         Original published format: US 840178 P
[2009/06]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007126825
Date:08.11.2007
Language:EN
[2007/45]
Type: A2 Application without search report 
No.:EP2019686
Date:04.02.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 08.11.2007 takes the place of the publication of the European patent application.
[2009/06]
Type: B1 Patent specification 
No.:EP2019686
Date:11.07.2012
Language:EN
[2012/28]
Search report(s)International search report - published on:EP05.06.2008
ClassificationIPC:A61K39/21
[2009/06]
CPC:
A61K39/21 (EP,US); A61K39/12 (EP,US); A61P31/18 (EP);
C07K14/005 (EP,US); A61K2039/54 (EP,US); A61K2039/543 (EP,US);
A61K2039/545 (EP,US); A61K2039/55544 (EP,US); A61K2039/55566 (EP,US);
C12N2740/16122 (EP,US); C12N2740/16134 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/06]
TitleGerman:KOMBINIERTE MUKOSALE UND PARENTERALE IMMUNISIERUNG GEGEN HIV[2009/06]
English:COMBINED MUCOSAL AND PARENTERAL IMMUNIZATION AGAINST HIV[2009/06]
French:IMMUNISATION MUCOSALE ET PARENTÉRALE COMBINÉE CONTRE LE VIH[2009/06]
Entry into regional phase03.10.2008National basic fee paid 
03.10.2008Designation fee(s) paid 
03.10.2008Examination fee paid 
Examination procedure03.10.2008Amendment by applicant (claims and/or description)
03.10.2008Examination requested  [2009/06]
02.03.2009Despatch of a communication from the examining division (Time limit: M04)
07.07.2009Reply to a communication from the examining division
05.12.2011Cancellation of oral proceeding that was planned for 06.12.2011
06.12.2011Date of oral proceedings (cancelled)
18.01.2012Communication of intention to grant the patent
22.05.2012Fee for grant paid
22.05.2012Fee for publishing/printing paid
Divisional application(s)EP11158008.0  / EP2382988
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.03.2009
Opposition(s)12.04.2013No opposition filed within time limit [2013/25]
Fees paidRenewal fee
03.10.2008Renewal fee patent year 03
15.03.2010Renewal fee patent year 04
15.03.2011Renewal fee patent year 05
14.03.2012Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.03.2007
AT11.07.2012
BE11.07.2012
CY11.07.2012
CZ11.07.2012
DK11.07.2012
EE11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
MT11.07.2012
NL11.07.2012
PL11.07.2012
RO11.07.2012
SE11.07.2012
SI11.07.2012
SK11.07.2012
TR11.07.2012
BG11.10.2012
GR12.10.2012
ES22.10.2012
IS11.11.2012
PT12.11.2012
IE29.03.2013
LU29.03.2013
CH31.03.2013
LI31.03.2013
MC31.03.2013
[2015/34]
Former [2015/32]AT11.07.2012
BE11.07.2012
CY11.07.2012
CZ11.07.2012
DK11.07.2012
EE11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
MT11.07.2012
NL11.07.2012
PL11.07.2012
RO11.07.2012
SE11.07.2012
SI11.07.2012
SK11.07.2012
TR11.07.2012
BG11.10.2012
GR12.10.2012
ES22.10.2012
IS11.11.2012
PT12.11.2012
IE29.03.2013
CH31.03.2013
LI31.03.2013
MC31.03.2013
Former [2014/32]AT11.07.2012
BE11.07.2012
CY11.07.2012
CZ11.07.2012
DK11.07.2012
EE11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
MT11.07.2012
NL11.07.2012
PL11.07.2012
RO11.07.2012
SE11.07.2012
SI11.07.2012
SK11.07.2012
BG11.10.2012
GR12.10.2012
ES22.10.2012
IS11.11.2012
PT12.11.2012
IE29.03.2013
CH31.03.2013
LI31.03.2013
MC31.03.2013
Former [2014/08]AT11.07.2012
BE11.07.2012
CY11.07.2012
CZ11.07.2012
DK11.07.2012
EE11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
NL11.07.2012
PL11.07.2012
RO11.07.2012
SE11.07.2012
SI11.07.2012
SK11.07.2012
BG11.10.2012
GR12.10.2012
ES22.10.2012
IS11.11.2012
PT12.11.2012
IE29.03.2013
CH31.03.2013
LI31.03.2013
MC31.03.2013
Former [2014/07]AT11.07.2012
BE11.07.2012
CY11.07.2012
CZ11.07.2012
DK11.07.2012
EE11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
NL11.07.2012
PL11.07.2012
RO11.07.2012
SE11.07.2012
SI11.07.2012
SK11.07.2012
BG11.10.2012
GR12.10.2012
ES22.10.2012
IS11.11.2012
PT12.11.2012
IE29.03.2013
MC31.03.2013
Former [2013/47]AT11.07.2012
BE11.07.2012
CY11.07.2012
CZ11.07.2012
DK11.07.2012
EE11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
NL11.07.2012
PL11.07.2012
RO11.07.2012
SE11.07.2012
SI11.07.2012
SK11.07.2012
BG11.10.2012
GR12.10.2012
ES22.10.2012
IS11.11.2012
PT12.11.2012
MC31.03.2013
Former [2013/34]AT11.07.2012
BE11.07.2012
CY11.07.2012
CZ11.07.2012
DK11.07.2012
EE11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
NL11.07.2012
PL11.07.2012
RO11.07.2012
SE11.07.2012
SI11.07.2012
SK11.07.2012
BG11.10.2012
GR12.10.2012
ES22.10.2012
IS11.11.2012
PT12.11.2012
Former [2013/23]AT11.07.2012
BE11.07.2012
CY11.07.2012
CZ11.07.2012
DK11.07.2012
EE11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
NL11.07.2012
PL11.07.2012
RO11.07.2012
SE11.07.2012
SI11.07.2012
SK11.07.2012
GR12.10.2012
ES22.10.2012
IS11.11.2012
PT12.11.2012
Former [2013/22]AT11.07.2012
BE11.07.2012
CY11.07.2012
CZ11.07.2012
DK11.07.2012
EE11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
NL11.07.2012
PL11.07.2012
SE11.07.2012
SI11.07.2012
GR12.10.2012
ES22.10.2012
IS11.11.2012
PT12.11.2012
Former [2013/21]AT11.07.2012
BE11.07.2012
CY11.07.2012
DK11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
NL11.07.2012
PL11.07.2012
SE11.07.2012
SI11.07.2012
GR12.10.2012
IS11.11.2012
PT12.11.2012
Former [2013/15]AT11.07.2012
BE11.07.2012
CY11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
NL11.07.2012
PL11.07.2012
SE11.07.2012
SI11.07.2012
GR12.10.2012
IS11.11.2012
PT12.11.2012
Former [2013/13]AT11.07.2012
BE11.07.2012
CY11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
PL11.07.2012
SE11.07.2012
SI11.07.2012
GR12.10.2012
IS11.11.2012
PT12.11.2012
Former [2013/12]AT11.07.2012
BE11.07.2012
CY11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
PL11.07.2012
SE11.07.2012
SI11.07.2012
GR12.10.2012
IS11.11.2012
Former [2013/11]AT11.07.2012
BE11.07.2012
CY11.07.2012
FI11.07.2012
LT11.07.2012
LV11.07.2012
PL11.07.2012
SI11.07.2012
GR12.10.2012
IS11.11.2012
Former [2013/10]AT11.07.2012
BE11.07.2012
CY11.07.2012
FI11.07.2012
LT11.07.2012
IS11.11.2012
Former [2013/09]AT11.07.2012
BE11.07.2012
FI11.07.2012
LT11.07.2012
Former [2013/08]AT11.07.2012
BE11.07.2012
LT11.07.2012
Former [2013/07]AT11.07.2012
Cited inInternational search[DA]WO02080648  (CHIRON CORP [US]) [DA] * figure 1 *;
 [X]US6511845  (DAVIS ALAN R [US], et al) [X] 1-4 * claim 6 *;
 [DX]WO03059385  (CHIRON CORP [US], et al) [DX] 1-4 * page 3, line 9 - line 11; claim 1 *;
 [X]  - VAJDY MICHAEL ET AL, "Mucosal and systemic anti-HIV responses in rhesus macaques following combinations of intranasal and parenteral immunizations", AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT, US, (200411), vol. 20, no. 11, ISSN 0889-2229, pages 1269 - 1281, XP002422502 [X] 1-4,6-19 * the whole document *

DOI:   http://dx.doi.org/10.1089/aid.2004.20.1269
 [X]  - SRIVASTAVA INDRESH K ET AL, "Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (200310), vol. 77, no. 20, ISSN 0022-538X, pages 11244 - 11259, XP002332880 [X] 1-4,6-19 * figure 11 *

DOI:   http://dx.doi.org/10.1128/JVI.77.20.11244-11259.2003
 [A]  - MCCLUSKIE MICHAEL J ET AL, "Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA", FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, ELSEVIER SCIENCE B.V., AMSTERDAM, NL, (20020218), vol. 32, no. 3, ISSN 0928-8244, pages 179 - 185, XP002288583

DOI:   http://dx.doi.org/10.1016/S0928-8244(01)00305-4
Examination   - LEWIS D ET AL, "Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin", PLOS ONE, (200909), vol. 4, no. 9, doi:DOI:10.1371/JOURNAL.PONE.0006999, ISSN 1932-6203
by applicant   - IBBA, BIOTECHNOL. GENET. ENG. REV, (1996), vol. 13, pages 197 - 216
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.